13-Butoxyberberine Bromide Inhibits Migration and Invasion in Skin Cancer A431 Cells.
The results showed that 13-butoxyberberine bromide effectively inhibited cell migration, invasion, and adhesion in A431 cells.
Skin Cancer · LIVING RESEARCH LIBRARY
Ongoing Research for Skin Cancer Using Advanced Alternative Medicine
Explore positive published findings by substance, cancer biology, treatment interaction and quality-of-life outcome.
Every entry includes the original study title, year, concise finding and a direct PubMed link.
Call 1.800.923.7878Ask About Your Skin Cancer Case
Tell us the diagnosis, stage, biomarkers, current treatment plan and research questions you want to understand. Our Patient Care Team will follow up personally.
Prefer to speak now?
Call 1.800.923.7878
Living research library · positive published findingsOpen study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed →
Research organized by substance and finding
Browse 6 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked substance to move directly to its corresponding Sunridge page.
Open study on PubMed →
Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma.
The gut microbiome is increasingly recognized to alter cancer risk, progression and response to treatments such as immunotherapy, especially in cutaneous melanoma.
Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma.
The gut microbiome is increasingly recognized to alter cancer risk, progression, and response to treatments such as immunotherapy, especially in cutaneous melanoma.
Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma.
UVR is the major cause of nonmelanoma skin cancer, but other risk factors, including immune suppression, chronic inflammation, and antibiotic usage, suggest the microbiome as an additional, unexplored risk factor and potential disease biomarker.
The importance of skin cancer prevention in organ transplant patients an editorial to paper by Salgo: 'switch to sirolimus in long-term renal transplant recipients: reduced premalignancies and nonmelanoma skin cancer in a controlled, prospective, randomized, blinded study'.
The study reports the importance of skin cancer prevention in organ transplant patients an editorial to paper by Salgo: 'switch to sirolimus in long-term renal transplant recipients: reduced premalignancies and nonmelanoma skin cancer in a controlled, prospective, randomized, blinded study'.
Vitamin D serum levels and non-melanoma skin cancer risk.
Despite the controversial data obtained in the literature, our results suggest that lower levels of vitamin D may be related to a reduced incidence of non-melanoma skin cancer.
No studies match those filters. Clear a filter or try a broader term.